Is it safe to get a computed tomography (CT) pulmonary angiogram at 34 weeks gestation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CT Pulmonary Angiography Safety at 34 Weeks Gestation

Yes, a CT pulmonary angiogram (CTPA) can be safely performed at 34 weeks gestation, but ventilation-perfusion (V/Q) scanning is preferred when available due to lower maternal breast radiation exposure. 1, 2

Diagnostic Approach for Suspected PE in Pregnancy

First-Line Imaging Recommendation

  • V/Q scanning is the preferred first-line imaging when available due to:
    • Lower maternal breast radiation exposure (3-4 mGy vs 7 mGy with CTPA) 1, 2
    • Similar diagnostic accuracy to CTPA in pregnancy 1
    • Comparable rates of false-negative results (0.5% for V/Q vs 0.4% for CTPA) 1

When CTPA is Appropriate

CTPA is an acceptable alternative in the following situations:

  • When V/Q scanning is not readily available 1
  • When the chest X-ray is abnormal 1, 2
  • In hemodynamically unstable patients requiring immediate diagnosis 2
  • At centers with expertise in low-dose CTPA techniques 3

Radiation Safety Considerations

Fetal Radiation Exposure

  • Fetal radiation dose from CTPA at 34 weeks is approximately 0.1-0.3 mGy 3, 4
  • This is well below the threshold associated with fetal complications (50-100 mSv) 1
  • The risk of childhood cancer from this exposure is extremely small 1

Maternal Radiation Exposure

  • Primary concern with CTPA is breast tissue exposure (2.9-7 mGy) 1, 3
  • Modern CTPA techniques have reduced this exposure significantly 1, 3
  • The lifetime cancer risk increase from a single CTPA is minimal (factor of 1.0003-1.0007) 1

Technical Considerations for CTPA in Late Pregnancy

Optimizing Image Quality

  • Late pregnancy (34 weeks) presents greater technical challenges for CTPA 5
  • Higher rates of suboptimal scans occur in late pregnancy (33.3%) compared to early pregnancy (11.1%) 5
  • Technical modifications to improve image quality include:
    • Automated bolus triggering
    • High iodine flux (flow rate 4.5-6 ml/s)
    • High iodine concentration (350-400 mg I/ml)
    • Clear breathing instructions to minimize Valsalva effects 1

Radiation Reduction Strategies

  • Shorter scan length (can reduce fetal dose by 56%) 4
  • mA modulation (can reduce dose by 10%) 4
  • Iterative reconstruction techniques 1
  • Reducing kilovoltage 1

Clinical Decision-Making Algorithm

  1. Initial assessment:

    • Evaluate clinical probability of PE
    • Consider D-dimer testing (though less useful in pregnancy)
    • Perform compression ultrasound if signs of DVT present
  2. Imaging selection:

    • If chest X-ray normal and V/Q scan available → Proceed with V/Q scan
    • If chest X-ray abnormal OR V/Q not available → Proceed with CTPA
    • If CTPA selected, ensure low-dose protocol is used
  3. If CTPA is performed:

    • Document radiation dose in medical records
    • Ensure proper technique to minimize maternal and fetal exposure
    • Have images reviewed by experienced radiologist

Important Caveats

  • The risk of missing a potentially fatal PE diagnosis far outweighs the minimal radiation risk 2
  • Empiric anticoagulation should be considered while awaiting imaging results if clinical suspicion is high and bleeding risk is low 1
  • Repeat CTPA should be avoided unless technical factors can be improved 1
  • Recent evidence from the OPTICA study confirms the safety of optimized low-dose CTPA protocols in pregnancy 3

Remember that while V/Q scanning is generally preferred, the most important consideration is obtaining a timely and accurate diagnosis using whichever modality is readily available at your institution.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.